[Course studies on cerebral glutamine excretion in schizophrenics under treatment with tranquilizing agents].
D000208:Acute Disease; D000249:Adenosine Monophosphate / Q000378:metabolism; D000255:Adenosine Triphosphate / Q000378:metabolism; D000328:Adult; D000641:Ammonia / Q000378:metabolism; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001921:Brain / Q000378:metabolism*; D003289:Convalescence; D005260:Female; D005973:Glutamine / Q000096:biosynthesis* / Q000097:blood; D006801:Humans; D006868:Hydrolysis; D008297:Male; D010640:Phenothiazines; D012075:Remission, Spontaneous; D012559:Schizophrenia / Q000097:blood / Q000188:drug therapy / Q000378:metabolism*; D014149:Tranquilizing Agents / Q000627:therapeutic use*
D014150:Antipsychotic Agents; D010640:Phenothiazines; D014149:Tranquilizing Agents; D005973:Glutamine; D000249:Adenosine Monophosphate; D000641:Ammonia; D000255:Adenosine Triphosphate
Verlaufsuntersuchungen zur zerebralen Glutaminausscheidung bei Schizophrenen unter Neurolepikabehandlung.